Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Abdominal Obesity

fluorodeoxyglucose f18 has been researched along with Abdominal Obesity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Boellaard, R; Borra, RJH; de Boer, SA; Greuter, MJ; Hillebrands, JL; Lambers Heerspink, HJ; Lefrandt, JD; Mulder, DJ; Reijrink, M; Slart, RHJA; Spoor, DS1
Fayad, ZA; Giles, JT; Grinspoon, SK; Hammad, B; Ishai, A; Koenen, KC; Lo, J; Oberfeld, B; Osborne, MT; Patrich, T; Pitman, RK; Shin, LM; Tawakol, A; Tung, B; Wang, Y1
Han, E; Jo, K; Kang, ES; Kim, G; Kim, KJ; Lee, YH; Wang, HJ; Yoon, HJ; Yun, M1
Bredella, MA; Cypess, AM; Fitch, K; Grinspoon, S; Lim, R; Sass, CA; Stavrou, E; Torriani, M1

Other Studies

4 other study(ies) available for fluorodeoxyglucose f18 and Abdominal Obesity

ArticleYear
Visceral adipose tissue volume is associated with premature atherosclerosis in early type 2 diabetes mellitus independent of traditional risk factors.
    Atherosclerosis, 2019, Volume: 290

    Topics: Adiposity; Adult; Aged; Atherosclerosis; Biomarkers; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Humans; Intra-Abdominal Fat; Male; Middle Aged; Obesity, Abdominal; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Tomography, X-Ray Computed

2019
Amygdalar Metabolic Activity Independently Associates With Progression of Visceral Adiposity.
    The Journal of clinical endocrinology and metabolism, 2019, 04-01, Volume: 104, Issue:4

    Topics: Adiposity; Adult; Aged; Amygdala; Bone Marrow; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Intra-Abdominal Fat; Male; Middle Aged; Obesity, Abdominal; Positron Emission Tomography Computed Tomography; Retrospective Studies; Stress, Psychological

2019
Visceral adiposity is associated with altered myocardial glucose uptake measured by (18)FDG-PET in 346 subjects with normal glucose tolerance, prediabetes, and type 2 diabetes.
    Cardiovascular diabetology, 2015, Nov-04, Volume: 14

    Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose; Heart; Humans; Intra-Abdominal Fat; Male; Middle Aged; Myocardium; Obesity, Abdominal; Positron-Emission Tomography; Prediabetic State; Radiopharmaceuticals; Subcutaneous Fat; Tomography, X-Ray Computed

2015
Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome.
    The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:4

    Topics: Adipose Tissue, Brown; Adiposity; Atrophy; Back; Biopsy; Cohort Studies; Energy Metabolism; Fluorodeoxyglucose F18; Glucose; HIV-Associated Lipodystrophy Syndrome; Humans; Hypertrophy; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Male; Middle Aged; Multimodal Imaging; Obesity, Abdominal; Positron-Emission Tomography; Subcutaneous Fat; Tissue Distribution; Tomography, X-Ray Computed; Up-Regulation

2012